Skip to main content
Premium Trial:

Request an Annual Quote

DiaGenic, GE Developing Test for Disorder Associated with Alzheimer's

The story has been updated to clarify the nature of the test in the headline.

NEW YORK (GenomeWeb News) – DiaGenic today announced a deal with GE Healthcare to develop a blood-based test using DiaGenic's gene expression profiling tools for the early detection of a disorder associated with Alzheimer's disease.

The two firms will conduct a study that combines DiaGenic's technology with a GE PET imaging agent to identify a blood-based gene expression signature in patients with mild cognitive impairment, which is associated with risk for AD. The deal is part of a broad portfolio of diagnostic tools under development by GE.

GE's PET imaging agent, 18F-flutemetamol, is in phase 3 development for the detection of beta amyloid and is not approved by any regulatory agency, DiaGenic said.

Oskar Hansson of Lund University and Skane University Hospital will be the principal investigator on the collaboration, and said that the goal is to recruit 180 patients with amnestic mild cognitive impairment, and 30 patients with clinically diagnosed mild to moderate AD.

The collaboration will combine expertise in data integration, informatics, genomics, and imaging in order to discover a biomarker that can be used to identify patients at risk of AD at the very early disease stage, Oslo-based DiaGenic said.

Innovation Norway is providing NOK2 million ($351,316) to the effort. Innovation Norway is an effort by the Norwegian government to develop businesses and industry in the country.

Financial and other terms of the partnership were not disclosed.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.